North America
Charles River and Akron Bio Advance Cell Therapy Manufacturing with Integration of Closed System Cytokines
Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio (“Akron”), a leading supplier of critical materials and services for a...
January 17, 2025 | News
Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data
Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...
January 17, 2025 | News
Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data
Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...
January 17, 2025 | News
Takara Bio Expands Spatial Genomics Portfolio with Curio Bioscience Acquisition
Takara Bio USA Holdings, announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. This strategic acquisition c...
January 16, 2025 | News
Lyndra Partners with Thermo Fisher to Drive Phase 3 Trials and Commercial Manufacturing of Long-Acting Oral Therapies
Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra...
January 16, 2025 | News
Simcere Zaiming and AbbVie Partner to Advance Novel Trispecific Antibody for Multiple Myeloma Treatment
Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement ...
January 14, 2025 | News
Argon Medical Devices Launches CLEAN-PE Study to Evaluate Cleaner™ Pro Thrombectomy System for Pulmonary Embolism Treatment
Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology proce...
January 13, 2025 | News
Complete Genomics Strengthens U.S. Manufacturing Footprint and Expands NGS Capabilities Amid Strategic Collaborations and Innovations
Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify i...
January 13, 2025 | News
SN BioScience Secures FDA IND Clearance for SNB-101 Phase 1b/2 Trial, Targeting Extensive Stage Small Cell Lung Cancer
SN BioScience announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administra...
January 13, 2025 | News
Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...
January 13, 2025 | News
Regor’s Oral GLP-1RA RGT-075 Shows 5% Placebo-Adjusted Weight Loss in Phase 2a Trial with Strong Safety Profile
Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no ...
January 13, 2025 | News
Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...
January 10, 2025 | News
Biocytogen and Acepodia Join Forces to Advance Precision Oncology with Dual-Payload Bispecific ADCs
Collaboration initiates development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs) Biocytogen’s RenLite® meets Acepodia’s...
January 08, 2025 | News
Verismo Therapeutics Secures $4.05M Investment from IFLI to Advance SynKIR™-310 for Follicular Lymphoma
Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). The partnership with...
January 08, 2025 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
